Clinical presentation and patterns of regional cerebral atrophy related to the length of trinucleotide repeat expansion in patients with adult onset Huntington's disease

Neuroscience Letters

Volumn 225, Issue 1, 1997, Pages 45-48

  Sieradzan, Katarzyna ^a   Mann, David M A ^b   Dodge, Alan ^c  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Brain atrophy; CAG repeat number; Genetics; Huntington's disease; Pathology

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ATROPHY; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; HISTOLOGY; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; PRIORITY JOURNAL; TRINUCLEOTIDE REPEAT;

ADOLESCENT; ADULT; AGE OF ONSET; ATROPHY; BRAIN; FEMALE; GENOTYPE; HUMANS; HUNTINGTON DISEASE; LINEAR MODELS; MALE; MIDDLE AGED; OLIGONUCLEOTIDES; PHENOTYPE; REPETITIVE SEQUENCES, NUCLEIC ACID;

EID: 0030982948     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00182-1     Document Type: Article

References (20)

1. Beal, M.F., Neurochemistry and toxin models in Huntington's disease, Curr. Opin. Neurol., 7 (1994) 542-547.
2. Brandt, J., Bylsma, F.W., Gross, R., Stine, O.C., Ranen, N. and Ross, C.A., Trinucleotide repeat length and clinical progression in Huntington's disease, Neurology, 46 (1996) 527-531.
3. Bruyn, G.W. and Went, L.N., Huntington's chorea. In P.J. Vinken, G.W. Bruyn and H.L. Klawans (Eds.), Extrapyramidal Disorders, Handbook of Clinical Neurology, Vol. 49, Elsevier Science, Amsterdam, 1986, pp. 267-313.
4. Burke, J.S., Enghild, J.J., Martin, M.E., Jou, Y.-S., Myers, R.M., Roses, A.D., Vance, J.M. and Strittmatter, W.J., Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH, Nature Med., 2 (1996) 347-350.
5. Claes, S., Van Zand, C., Legius, E., Dom, R., Malfroid, M., Baro, F., Godderis, J. and Cassiman, J.J., Correlations between triplet repeat expansion and clinical features in Huntington's disease, Arch. Neurol., 113 (1995) 749-753.
6. De La Monte, S.M., VonSattel, J.-P. and Richardson, E.P., Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease, J. Neuropathol. Exp. Neurol., 47 (1988) 516-525.
7. Furtado, S., Suchowersky, O., Rewcastle, B., Graham, L., Klimek, M.L. and Garber, A., Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease, Ann. Neurol., 39 (1996) 132-136.
8. Godfrey, K., Statistics in practice: comparing the means of several groups, N. Eng. J. Med., 313 (1985) 1450-1456.
9. Kieburtz, K., MacDonald, M., Shih, C., Feigin, A., Steinberg, K., Bordwell, K., Zimmerman, C., Srinidhi, J., Sotack, J., Gusella, J. and Shoulson, I., Trinucleotide repeat length and progression of illness in Huntington's disease, J. Med. Genet., 31 (1994) 872-874.
10. Landwehrmeyer, G.B., McNeil, S.M. and Dure, L.S., IV., Ge, P., Aizawa, H., Huang, Q., Ambrose, C.M., Duayo, M.P., Bird, E.D., Bonilla, E., de Young, M., Avila-Gonzalez, A.J., Wexler, N.S., DiFiglia, M., Gusella, J.F., MacDonald, M.E., Penney, J.B., Young, A.B. and Vonsattel, J.-P., Huntington's disease gene: regional and cellular expression in brain of normal and affected individuals, Ann. Neurol., 37 (1995) 218-230.
11. Li, X.-J., Li, S.-H., Sharp, A.H., Nucifora, F.C. Jr., Schilling, G., Lanahan, A., Worley, P., Snyder, S.H. and Ross, C.A., A huntingtin-associated protein enriched in brain with implications for pathology, Nature, 378 (1995) 398-402.
12. Mann, D.M.A., The topographic distribution of brain atrophy in Alzheimer's disease, Acta Neuropathol., 83 (1991) 81-86.
13. Mann, D.M.A., Oliver, R. and Snowden, J.S., The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy, Acta Neuropathol., 85 (1993) 553-559.
14. Neal, J.W., Fenton, I., MacMillan, J.C., Tyler, A., Ball, D., Shaw, D.J., Harper, P.S. and Snell, R.G., A study comparing mutation triplet repeat size and phenotypes in patients with Huntington's disease, Neurodegeneration, 3 (1994) 73-77.
15. Roos, R.A.C., Hermans, J., Vegter-van de Vlis, M., Ommen van, G.J.B. and Bruyn, G.W., Duration of illness in Huntington's disease is not related to age at onset, J. Neurol. Neurosurg. Psychiatry, 56 (1993) 98-100.
16. Snell, R.G., MacMillan, J.C., Cheadle, J.P., Fenton, I., Lazarou, L.P., Davies, P., MacDonald, M.E., Gusella, J.F., Harper, P.S. and Shaw, D.J., Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington disease, Nature Genet., 4 (1993) 393-397.
17. The Huntington's Disease Collaborative Research Group, A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes, Cell, 72 (1993) 971-983.
18. VonSattel, J.-P., Myers, R.H., Stevens, T.J., Ferrante, R.J., Bird, E.D. and Richardson, E.P., Neuropathological classification of Huntington's disease, J. Neuropathol. Exp. Neurol., 44 (1985) 559-577.
19. Warner, J.P., Barron, L.H. and Brock, D.J., A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes, Mol. Cell Probes, 7 (1993) 235-239.
20. Xuerb, J.H., MacMillan, J.C., Snell, R., Davies, P. and Harper, P.S., Neuropathological diagnosis and CAG repeat expansion in Huntington's disease, J. Neurol. Neurosurg. Psychiatry, 60 (1996) 78-81.